Streptococcus pyogenes cell envelope protease (SpyCEP) (SpyCEP)

Streptococcus pyogenes cell envelope protease (SpyCEP), also known as ScpC, is a large, cell-surface-anchored serine protease produced by Group A Streptococcus (GAS) (Hidalgo-Grass et al., 2004). Its primary biological function is the highly specific cleavage and inactivation of C-X-C chemokines, particularly Interleukin-8 (IL-8/CXCL8), which is essential for recruiting neutrophils to infection sites (Edwards et al., 2005). By degrading these signaling molecules, SpyCEP effectively creates a 'chemokine-free' zone around the bacteria, preventing the host's innate immune system from mounting an effective cellular response (Zinkernagel et al., 2008). This immune evasion mechanism is a critical driver of invasive GAS diseases, such as necrotizing fasciitis and streptococcal toxic shock syndrome, where rapid bacterial dissemination occurs in the absence of a robust neutrophil infiltrate (Turner et al., 2009). As a major virulence factor, SpyCEP is a primary target for the development of novel therapeutics, including subunit vaccines like the Combo5 candidate and neutralizing antibodies designed to restore neutrophil-mediated clearance of the pathogen (Dale et al., 2016).

Other names

ScpCCepAStreptococcus pyogenes chemokine-cleaving proteaseC-X-C chemokine-degrading protease

Inhibition of the protease's catalytic activity to prevent the cleavage and inactivation of host chemokines like IL-8, thereby restoring the host's ability to recruit neutrophils to the site of infection.